Ignite Creation Date:
2024-05-06 @ 1:00 AM
Last Modification Date:
2024-10-26 @ 10:57 AM
Study NCT ID:
NCT01708304
Status:
COMPLETED
Last Update Posted:
2017-09-15
First Post:
2012-10-09
Brief Title:
Reducing Disabilities in Alzheimers Disease RDAD Translation in Area Agencies on Aging AAAs
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
From Evidence-Base to Practice Implementing RDAD in AAA Community-Based Services
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RDAD
Brief Summary:
The University of Washingtons Northwest Research Group on Aging is partnering with Area Agencies on Aging AAA in Washington and Oregon to complete this translational investigation of RDAD Reducing Disabilities in Alzheimers Disease RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy This study asks two questions 1 Can AAA partners successfully translate and implement RDAD and 2 Is AAA implementation of RDAD effective in producing desired outcomes among agencies providers and older adults with dementia and their family members This study is being conducted in Washington and Oregon states
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None